Developing essential medicines

ath_who1

32 medicines developed by Roche are included in the WHO Model Lists of Essential Medicines. Thirty of these are patent-free and include many important antibiotics, anti-malarials and chemotherapy drugs.

The WHO core list contains medicines believed to be required for a basic healthcare system, including the most efficacious, safe and cost effective medicines for priority conditions. The WHO Model List serves as a guide for the development of national and institutional essential medicine lists.

Roche products on the WHO Model List of Essential Medicines (2019)
Product Treatment area
alteplase (Activase) Cardiovascular diseases
amitriptyline (Laroxyl) Anti-depressant / Pallative care
ascorbic acid (Redoxon) Vitamin C deficiency
benznidazole (Radanil, Rochagan) American trypanosomiasis (Chagas disease)
capecitabine (Xeloda) Breast, colon and rectal cancer
ceftriaxone (Rocephin) Broad-spectrum cephalosporin antibiotic
cycloserine (D-Cycloserine) Pulmonary tuberculosis
diazepam (Valium) Tranquilizer
epoietin beta (NeoRecormon) Anaemia associated with chronic kidney disease
erlotinib (Tarceva) EGFR mutation positive non-small cell lung cancer
flucytosine (Ancotil) Antifungal medicine
fluorouracil (Fluorouracil) Chemotherapeutic agent
heparin sodium (Liquemin) Anti-coagulation agent
isoniazid (Rimifon) Tuberculosis
levodopa + benserazide (Madopar) Parkinson's disease
mefloquine (Lariam) Malaria
methoxy polyethylene glycol-epoietin beta (Mircera) Anaemia associated with chronic kidney disease
midazolam (Dormicum) Sedation/ Palliative care
neostigmine (Prostigmin) Myasthenia gravis/ Anaesthesia
oseltamivir (Tamiflu) Anti-viral/ Influenza
pegylated interferon alpha 2a or 2b (Pegasys) Anti-viral/ Hepatitis C
phytomenadione (Konakion) Anti-coagulation agent
procarbazine (Natulan) Hodgkin's lymphoma
protamine hydrochloride (Protamin) Heparin antagonist
pyridostigmine (Mestinon) Myasthenia gravis
retinol (Arovit) Vitamin A deficiency
rituximab (MabThera/Rituxan) Non Hodgkin's lymphoma, chronic lymphocytic leukemia
sulfadoxine + pyrimethamine (Fansidar) Malaria
sulfamethoxazole + trimethoprim / co-trimoxazole (Bactrim) Anti-bacterial agent
thiamine (Berolase) Heart failure/Vitamin B1 deficiency
trastuzumab (Herceptin) Breast cancer
valganciclovir (Valcyte) Cytomegalovirus

For more information see: www.who.int/medicines/publications/essentialmedicines/en

More stories

Tags: Access to healthcare